UC San Diego Finds Liver Enzyme Key to Beating Addiction

Scientists at UC San Diego just turned addiction research on its head by discovering that the secret to fighting cocaine addiction might be hiding in the liver, not just the brain.

In the largest genetic study of its kind, researchers analyzed nearly 900 genetically diverse rats to map out what makes some individuals vulnerable to addiction while others stay resistant. What they found shocked them: a liver enzyme called Ces1 significantly influences whether someone develops compulsive drug use.

"Finding a liver-based enzyme that shapes cocaine-taking behavior was a real 'aha' moment for us," said Dr. Olivier George, professor of psychiatry at UC San Diego School of Medicine. "It reminds us that addiction isn't only in the brain."

The research team identified Ces1 genes that create enzymes responsible for breaking down cocaine in the body. Variations in these genes directly linked to how frequently and compulsively the rats used the drug.

This matters because current addiction treatments almost exclusively target the brain. If scientists can develop medicines that change how Ces1 enzymes work, they might be able to reduce cocaine's addictive impact before it even reaches the brain.

The study, published in Nature Communications, also replicated a genetic link previously found in humans, strengthening the bridge between animal research and real treatments. The researchers used a special rat model that mimics human genetic diversity, making their findings more likely to translate to people.

Dr. Montana Kay Lara, the study's first author, called it "incredibly exciting" to validate a hypothesis that scientists have wondered about for decades. "It gives us a concrete target to test whether changing how cocaine is metabolized can blunt the drive toward compulsive use."

Why This Inspires

This discovery represents a decade of collaborative effort between behavioral scientists and geneticists working together toward one goal: helping people break free from addiction. The team built extensive biobanks of tissue samples that other researchers worldwide can now use to find biological markers predicting addiction risk.

The researchers are already moving into the next phase, investigating exactly how genetic mutations change enzyme function. Their hope is to one day identify people at high risk before addiction develops and offer preventive treatments tailored to their genetic makeup.

For the millions of families touched by substance use disorders, this research offers something precious: a completely new avenue for treatment where none existed before.